Back

Key opinion leaders review clinical cases in systemic mastocytosis, focusing on therapeutic options and diagnostic criteria.

Systemic Mastocytosis

Episodes

Specialty:

All

Year:

All

EP. 1: Systemic Mastocytosis: Epidemiology and Diagnostic Criteria

ByDaniel J. DeAngelo, MD, PhD, Dana-Farber Cancer Institute,Sa Wang, MD, MD Anderson Cancer Center,Prithviraj Bose, MD, MD Anderson Cancer Center,Patricia Lugar, MD, MS, Duke Health

August 2nd 2021

Experts in the field of mast cell disorders discuss the epidemiology and diagnostic criteria of systemic mastocytosis.

EP. 2: Considerations in Mast Cell Disorders

ByDaniel J. DeAngelo, MD, PhD, Dana-Farber Cancer Institute,Sa Wang, MD, MD Anderson Cancer Center,Prithviraj Bose, MD, MD Anderson Cancer Center,Patricia Lugar, MD, MS, Duke Health

August 2nd 2021

The panel of experts highlights the importance of assessing symptomology and clinical characteristics in mast cell disorders.

EP. 3: Considerations in SM: Hereditary Alpha Tryptasemia

ByDaniel J. DeAngelo, MD, PhD, Dana-Farber Cancer Institute,Sa Wang, MD, MD Anderson Cancer Center,Prithviraj Bose, MD, MD Anderson Cancer Center,Patricia Lugar, MD, MS, Duke Health

August 9th 2021

Prithviraj Bose, MD, and Patricia Lugar, MD, MS, discuss the considerations and testing options for hereditary alpha tryptasemia in patients with systemic mastocytosis.

EP. 4: Case 1: 75-Year-Old Man With SM

ByDaniel J. DeAngelo, MD, PhD, Dana-Farber Cancer Institute,Sa Wang, MD, MD Anderson Cancer Center,Prithviraj Bose, MD, MD Anderson Cancer Center,Patricia Lugar, MD, MS, Duke Health

August 9th 2021

Dan DeAngelo, MD, PhD, presents the case of a 75-year-old man with systemic mastocytosis and reviews WHO diagnostic criteria.

EP. 5: Case 1: Treatment and Management Considerations

ByDaniel J. DeAngelo, MD, PhD, Dana-Farber Cancer Institute,Sa Wang, MD, MD Anderson Cancer Center,Prithviraj Bose, MD, MD Anderson Cancer Center,Patricia Lugar, MD, MS, Duke Health

August 16th 2021

The panel of experts in SM discuss the diagnosis and management of a 75-year-old man with systemic mastocytosis.

EP. 6: Case 1: Treatment Algorithm and Supportive Care Recommendations

ByDaniel J. DeAngelo, MD, PhD, Dana-Farber Cancer Institute,Sa Wang, MD, MD Anderson Cancer Center,Prithviraj Bose, MD, MD Anderson Cancer Center,Patricia Lugar, MD, MS, Duke Health

August 16th 2021

Patricia Lugar, MD, MS, shares treatment algorithm and supportive care recommendations for a 75-year-old man with systemic mastocytosis.

EP. 7: Case 2: 46-year-old Woman With SM

ByDaniel J. DeAngelo, MD, PhD, Dana-Farber Cancer Institute

August 23rd 2021

Dan DeAngelo, MD, PhD, presents the case of a 46-year-old woman with systemic mastocytosis and associated gastrointestinal symptoms.

EP. 8: Case 2: Treatment and Management Considerations for SM

ByDaniel J. DeAngelo, MD, PhD, Dana-Farber Cancer Institute,Prithviraj Bose, MD, MD Anderson Cancer Center,Sa Wang, MD, MD Anderson Cancer Center

August 23rd 2021

The panel of experts in SM discuss the diagnosis and management of a 46-year-old woman with systemic mastocytosis.

EP. 9: Case 2: SM Treatment Algorithm and Supportive Care Recommendations

ByDaniel J. DeAngelo, MD, PhD, Dana-Farber Cancer Institute,Patricia Lugar, MD, MS, Duke Health

August 30th 2021

Patricia Lugar, MD, MS, shares an allergist’s perspective regarding treatment algorithms and supportive care recommendations for patients with systemic mastocytosis.

EP. 10: PATHFINDER Trial Efficacy Data

ByDaniel J. DeAngelo, MD, PhD, Dana-Farber Cancer Institute

August 30th 2021

Dan DeAngelo, MD, PhD, reviews key efficacy data from the phase II PATHFINDER study.

EP. 11: Avapritinib: Approval and Clinical Practice Implications

ByDaniel J. DeAngelo, MD, PhD, Dana-Farber Cancer Institute,Prithviraj Bose, MD, MD Anderson Cancer Center,Patricia Lugar, MD, MS, Duke Health

September 7th 2021

A panel of experts share their reactions to the approval of avapritinib and discuss the clinical implications.

EP. 12: Case 3: Indolent Systemic Mastocytosis

ByDaniel J. DeAngelo, MD, PhD, Dana-Farber Cancer Institute,Patricia Lugar, MD, MS, Duke Health,Prithviraj Bose, MD, MD Anderson Cancer Center

September 7th 2021

Dan DeAngelo, MD, PhD, presents the case of a patient with indolent systemic mastocytosis and urticaria pigmentosa.

EP. 13: Case 4: A 68-Year-Old Female With Mast Cell Leukemia

BySa Wang, MD, MD Anderson Cancer Center

September 13th 2021

Sa Wang, MD, presents the case of a 68-year-old female with mast cell leukemia.

EP. 14: Case 4: Treatment and Management Considerations in MCL

BySa Wang, MD, MD Anderson Cancer Center,Daniel J. DeAngelo, MD, PhD, Dana-Farber Cancer Institute,Prithviraj Bose, MD, MD Anderson Cancer Center

September 13th 2021

The panel of experts in SM discuss the diagnosis and treatment of a 68-year-old female with mast cell leukemia.

EP. 15: Advanced Systemic Mastocytosis: Expert Insight into Epidemiology, Diagnosis, and Treatment

ByDaniel J. DeAngelo, MD, PhD,Sa Wang, MD,Patricia L. Lugar, MD, MS,Prithviraj Bose, MD

September 15th 2021

Learn more about the epidemiology, diagnosis, and treatment of advanced systemic mastocytosis in this summary from an expert multidisciplinary case-based discussion.